Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
Market Capitalization: 135.31 M
The data is delayed by 15 minutes.
CARA is in the long-term up 151% in 6 years.
Description: Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors. Its lead product candidate includes intravenous CR845, which has completed Phase II clinical trials for the treatment acute postoperative pain in adult patients. The company is also developing Oral CR845 that has completed Phase I clinical trial for the treatment of moderate-to-severe acute and chronic pain; and CR701, which is in preclinical trial for treating neuropathic and inflammatory pain. Cara Therapeutics, Inc. was founded in 2004 and is based in Shelton, Connecticut.
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||27.28 M||EPS||-2.52||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||-49.06%||Sales Growth - Q/Q||-46.5%||P/E||-6.79|
|P/E To EPS Growth||P/S||38.79||P/BV||2.85||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-36.88%||ROE||-40.17%||ROI|
|Current Ratio||14.31||Quick Ratio||Long Term Debt/Equity||Debt Ratio||0.07|
|Gross Margin||Operating Margin||-555.3%||Net Profit Margin||-546.19%||Dividend Payout Ratio|
|Cash From Financing Activities||10 K||Cash From Investing Activities||-10 K||Cash From Operating Activities||-5.24 M||Gross Profit|
|Net Profit||-4.69 M||Operating Profit||-4.72 M||Total Assets||51.65 M||Total Current Assets||49.06 M|
|Total Current Liabilities||3.43 M||Total Debt||800 K||Total Liabilities||4.23 M||Total Revenue||490 K|
|High 52 week||23.95||Low 52 week||11.6||Last close||19.03||Last change||-0.68%|
|RSI||46.55||Average true range||0.99||Beta||1.6||Volume||1.26 M|
|Simple moving average 20 days||0.06%||Simple moving average 50 days||0.02%||Simple moving average 200 days||4.44%|
|Performance Week||1.17%||Performance Month||5.31%||Performance Quart||11.61%||Performance Half||0.69%|
|Performance Year||53.47%||Performance Year-to-date||46.38%||Volatility daily||2.89%||Volatility weekly||6.46%|
|Volatility monthly||13.24%||Volatility yearly||45.87%||Relative Volume||252.99%||Average Volume||692.03 K|
|New High||New Low|
2020-05-27 16:01:10 | Cara Therapeutics to Present at the Jefferies Virtual Healthcare Conference
2020-05-15 11:00:03 | Is Cara Therapeutics CARA Stock a Solid Choice Right Now?
2020-05-12 09:30:46 | Edited Transcript of CARA earnings conference call or presentation 11-May-20 8:30pm GMT
2020-05-12 06:00:46 | Cara Therapeutics Inc CARA Q1 2020 Earnings Call Transcript
2020-05-11 17:55:09 | Cara Therapeutics CARA Reports Q1 Loss, Tops Revenue Estimates
2020-05-11 16:01:10 | Cara Therapeutics Reports First Quarter 2020 Financial Results
2020-05-07 07:00:10 | Cara Therapeutics to Present at the Virtual BofA Securities 2020 Health Care Conference
2020-05-04 16:01:10 | Cara Therapeutics to Announce First Quarter 2020 Financial Results on May 11, 2020
2020-04-29 07:14:00 | Better Buy: Cara Therapeutics vs. Sangamo Therapeutics
2020-04-29 07:03:07 | Will Cara Therapeutics NASDAQ:CARA Spend Its Cash Wisely?
2020-04-28 12:34:04 | Earnings Preview: Cara Therapeutics CARA Q1 Earnings Expected to Decline
2020-04-21 08:07:12 | Cara Therapeutics' Shares March Higher, Can It Continue?
2020-04-21 01:30:10 | Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma Announce Positive Results From Global KALM-2 Pivotal Phase 3 Trial of KORSUVATM Injection in Hemodialysis Patients with Pruritus
2020-04-08 07:00:10 | Cara Therapeutics to Present at the Virtual 19th Annual Needham Healthcare Conference
2020-03-25 07:00:10 | Cara Therapeutics Reports Clinical Updates
2020-03-20 16:53:46 | Edited Transcript of CARA earnings conference call or presentation 27-Feb-20 9:30pm GMT
2020-03-10 13:45:02 | 3 Beaten-Down Biotech Stocks With Catalysts Just Around the Corner
2020-02-29 08:05:51 | Cara Therapeutics, Inc. Just Reported And Analysts Have Been Cutting Their Estimates
2020-02-27 17:55:10 | Cara Therapeutics CARA Reports Q4 Loss, Misses Revenue Estimates
2020-02-27 16:01:10 | Cara Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
2020-02-03 06:12:51 | Does Cara Therapeutics, Inc.'s NASDAQ:CARA CEO Salary Reflect Performance?
2020-01-08 16:01:10 | Cara Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
2019-12-19 21:32:15 | Was Smart Money Right About Piling Into Cara Therapeutics Inc CARA in September?
2019-12-06 16:01:10 | Cara Therapeutics Announces Equity Grants to Employees Under Inducement Plan
2019-12-04 10:02:03 | Biotech Stock Roundup: Pipeline Updates From BIIB, AXSM, CARA, Collaborations & More
2019-12-04 07:14:09 | Investors Who Bought Cara Therapeutics NASDAQ:CARA Shares Three Years Ago Are Now Up 78%
2019-12-03 16:01:10 | Cara Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference
2019-11-18 13:03:03 | Top Marijuana Stocks for November 2019
2019-11-13 09:12:02 | Is the Options Market Predicting a Spike in Cara Therapeutics CARA Stock?
2019-11-12 16:01:00 | Cara Therapeutics to Present at November Investor Conferences
2019-11-06 04:08:22 | Edited Transcript of CARA earnings conference call or presentation 5-Nov-19 9:30pm GMT
2019-11-05 18:35:11 | Cara Therapeutics CARA Reports Q3 Loss, Tops Revenue Estimates
2019-11-05 16:01:00 | Cara Therapeutics Reports Third Quarter 2019 Financial Results
2019-11-01 07:00:05 | Cara Therapeutics Announces Presentations at Kidney Week 2019
2019-10-29 16:01:05 | Cara Therapeutics to Announce Third Quarter 2019 Financial Results on November 5, 2019
2019-10-28 19:55:55 | Here’s What Hedge Funds Think About Casa Therapeutics Inc CARA
2019-10-20 08:45:42 | Have Insiders Been Selling Cara Therapeutics, Inc. NASDAQ:CARA Shares?
2019-10-14 07:00:00 | Cara Therapeutics Announces Completion of Interim Statistical Assessment and Small Increase in Target Enrollment for KALM-2 Phase 3 Global Trial of KORSUVA™ Injection in Hemodialysis Patients with Pruritus
2019-10-01 14:23:51 | First cannabis cafe in the U.S. opens in Los Angeles
2019-09-26 16:01:00 | Cara Therapeutics to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
2019-09-19 10:11:28 | How Much Of Cara Therapeutics, Inc. NASDAQ:CARA Do Institutions Own?
2019-08-21 16:24:33 | Cara Therapeutics Inc CARA Q2 2019 Earnings Call Transcript
2019-08-21 11:44:43 | 10 Marijuana Stocks That Could See 100% Gains, If Not More